Study Details
A Phase 3 efficacy, safety and tolerability study of zolbetuximab (experimental drug) plus mFOLFOX6 chemotherapy compared to placebo plus mFOLFOX6 as treatment for gastric and gastroesophageal junction (GEJ) cancer
Clinicaltrials.gov ID
Astellas Study ID
8951-CL-0301
EudraCT ID
2017-002567-17
Condition
Stomach or Esophageal Cancer
Phase
Phase 3
Age
18 Years - N/A N/A
Sex
Female & Male
Product
zolbetuximab
Type
Interventional
Trial Dates
Jun 2018 - Jan 2025
Masking
Double (Participant, Investigator)
Enrollment number
566
A Phase 3, Global, Multi-Center, Double-Blind, Randomized, Efficacy Study of zolbetuximab (IMAB362) Plus mFOLFOX6 Compared with Placebo Plus mFOLFOX6 as First-line Treatment of Subjects with Claudin (CLDN)18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Phase 3 efficacy, safety and tolerability study of zolbetuximab (experimental drug) plus mFOLFOX6 chemotherapy compared to placebo plus mFOLFOX6 as treatment for gastric and gastroesophageal junction (GEJ) cancer? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site JP81007
Sapporo, Japan
Site JP81012
Sunto-gun, Japan
Oregon Health & Science University
Portland, United States, 97239
Site DE49007
Munchen, Germany, 81925
Site KR82009
Suwon-si, Republic of Korea, 16247
Site BR55003
Santo Andre, Brazil, 09060-650
Site DE49010
Dresden, Germany, 01307
Site GB44104
Dundee, United Kingdom, DD2 4BF
Site DE49017
Berlin, Germany, 12200
Site DE49011
Berlin, Germany, 13353
Site FR33101
St Herblain, France, 44805
Site BR55017
Belo Horizonte, Brazil, 30130-090
University of Oklahoma Health Science Center
Oklahoma City, United States, 73104
Site JP81005
Fukuoka, Japan
Toledo Clinic Cancer Center - Toledo
Toledo, United States, 43623
Site IT39022
Reggio Emilia, Italy, 42123
Site BE32005
Brugge, Belgium, 8310
University of Maryland Medical Center(UMMC)Transplant Center
Baltimore, United States, 21201
Site BR55006
Lajeado, Brazil, 95900000
Loma Linda University
Loma Linda, United States, 92354
Site TW88604
Kaohsiung, Taiwan, Province of China, 833
Site BE32011
Charleroi, Belgium, 6000
Site CO57006
Medellín, Colombia, 574
Site IT39026
Terni, Italy, 5100
Site IL97201
Haifa, Israel, 3109601
Seattle Cancer Care Alliance
Seattle, United States, 98109
Site DE49019
Heilbronn, Germany, 74078
Site PL48002
Brzozow, Poland, 36-20
University of California Davis
Sacramento, United States, 95817
Site CA15002
Montreal, Canada, H3T 1M5
Site IT39006
Milano, Italy, 20132
Site KR82003
Seoul, Republic of Korea, 03080
Site IT39013
Ancona, Italy, 60126
The University of Arizona Medical Center
Tucson, United States, 85724
Orlando Health Inc
Orlando, United States, 32806
Northwestern University Medical Center
Chicago, United States, 60611
Site BR55005
Sao Jose do Rio Preto, Brazil, 15090-000
Site MX52003
Distrito Federal, Mexico, 06720
Site PE51005
Lima, Peru, 15036
Site ES34017
Madrid, Spain, 28033
Site KR82007
Seoul, Republic of Korea, 152-703
Cancer Treatment Centers of America, Phoenix
Goodyear, United States, 85338
Site BE32010
Haine-Saint-Paul, Belgium, 7100
Site DE49012
Berlin, Germany, 13125
Site GB44103
Cambridge, United Kingdom, CB2 0QQ
Site FR33002
Paris cedex, France, 75970
Site DE49015
Magdeburg, Germany, 39104
Site IT39009
Cremona, Italy, 26100
Site FR33010
Brest Cedex, France, 29609
Site GB44001
Manchester, United Kingdom, M20 4BX
Site CN86008
Zhengzhou, China, 450000
Site PL48004
Lublin, Poland, 20-090
St Lukes Hospital Association of Duluth
Duluth, United States, 55805
Site IT39003
Piacenza, Italy, 29100
Site GB44009
Coventry, United Kingdom, CV2 2DX
Mount Sinai School of Medicine
New York, United States, 10029-6574
Regions Hospital
St. Paul, United States, 55101
Stony Brook University Medical Center
Stony Brook, United States, 11794-9452
Site TW88605
Kwei-Shan, Taiwan, Province of China, 333
Site GB44102
Sutton, United Kingdom, SM2 5PT
Site BR55010
Brasília, Brazil, 70200-730
Site ES34016
BARCELONA, Spain, 08025
Site CN86003
Haerbin, China, 150081
Site TW88601
Taipei, Taiwan, Province of China, 112
Site CL56003
Providencia, Chile, 7500921
Site IT39016
Padova, Italy, 35128
Site GB44006
Edinburgh, United Kingdom, EH4 2XU
Site CO57007
Monteria, Colombia, 230002
Karmanos Cancer Institute
Detroit, United States, 48201
Site CL56007
Valdivia, Chile, 5090000
Site FR33001
Rennes, France, 35042
Site CN86004
Hangzhou Shi, China, 310003
University of Colorado
Aurora, United States, 80045
Site CO57002
Medellin, Colombia, 0574
Site JP81008
Koto-ku, Japan
Site JP81010
Kitaadachi-gun, Japan
Memorial Sloan Kettering Cancer Center
Montvale, United States, 07645
Site FR33009
Dijon, France, 21079
Inova Dwight and Martha Schar Cancer Institute
Fairfax, United States, 22031
Site ES34013
Badalona, Spain, 08028
Site JP81009
Nagoya, Japan
Cancer Treatment Centers of America, Philadelphia
Philadelphia, United States, 19124
Site BR55002
Itajai, Brazil, 88301-220
Site DE49008
Munich, Germany, 81377
Site ES34008
Madrid, Spain, 28007
Site JP81003
Kashiwa, Japan
Site CO57001
Cali, Colombia
Site ES34019
Burgos, Spain, 09006
Site AU61006
East Bentleigh, Australia, 3165
Site JP81014
Kobe, Japan
Site IL97208
Petah-Tikva, Israel, 4941492
University of California - San Francisco
San Francisco, United States, 94143
Site IL97210
HaDarom, Israel, 7030000
Precision Cancer Research -Dayton Physicians Network
Middletown, United States, 45042
Memorial Cancer Institute - West
Hollywood, United States, 33021
Site CA15008
Montreal, Canada, H4A 3J1
Site FR33008
Besancon cedex, France, 25033
Site BE32012
Gent, Belgium, 9000
Site BR55007
Barretos, Brazil, 14784-400
Site BE32007
Edegem, Belgium, 2650
Site JP81004
Osaka, Japan
Earle A. Chiles Research Institute
Portland, United States, 97213
Site CN86006
Nanjing, China, 210008
Site DE49004
Leipzig, Germany, 04103
Site ES34018
Sevilla, Spain, 41009
Site KR82006
Seoul, Republic of Korea, 6591
Site GB44008
Leeds, United Kingdom, LS7 9TF
Site PE51004
San Isidro, Peru, L27
Site FR33003
Lyon, France, 69008
Site AU61007
Kogarah, Australia, 2217
Site MX52001
Aguascalientes, Mexico, 20230
Cancer Treatment Centers of America, Atlanta
Newman, United States, 30265
Site JP81006
Chuo-ku, Japan
The University of Texas MD Anderson Cancer Center
Houston, United States, 77030
Site CN86001
Xiamen, China
Site ES34006
Zaragoza, Spain, 50009
Site IT39018
Perugia, Italy, 05100
Site TW88607
Tainan, Taiwan, Province of China, 704
Site BE32001
Bruxelles, Belgium, 1200
Thomas Jefferson University
Philadelphia, United States, 19107
Site PL48001
Warszawa, Poland, 02-034
Site MX52002
Mexico, Mexico, 06760
Site IT39014
Bergamo, Italy, 24125
Site KR82008
Incheon, Republic of Korea, 21556
Site BR55009
São Paulo, Brazil, 01509-900
Health Partners Institute
St. Louis Park, United States, 55426
Mount Sinai School of Medicine
New York, United States, 10019-1147
Site BR55015
Rio de Janeiro, Brazil, 22793-080
Site IL97203
Tel Aviv, Israel, 64239
Sanford Cancer Center
Sioux Falls, United States, 57104
Site PE51003
Arequipa, Peru, 4001
Site IT39021
Modena, Italy, 41124
Site BR55004
São Paulo, Brazil, 08270-070
Lancaster General Hospital
Lancaster, United States, 17604
Site CA15005
Edmonton, Canada, T6G 1Z2
Site JP81002
Matsuyama, Japan
Site IT39024
Turin TO, Italy, 5-10126
CBCC Global Research, Inc. at Comprehensive Blood and Cancer
Bakersfield, United States, 93309
Memorial Sloan Kettering Cancer Center
Commack, United States, 11725
Site IT39019
Pisa, Italy, 56126
Site JP81015
Hidaka, Japan
Gene Upshaw Memorial Tahoe Forest Cancer Center - Pharmacy
Truckee, United States, 96161
Site IT39020
Monza, Italy, 20052
Site FR33103
Creteil, France, 94000
University of Arizona
Phoenix, United States, 85004
Massachusetts General Hospital
Boston, United States, 02114-2696
Site JP81013
Bunkyo-ku, Japan
Site CL56008
Providencia, Chile, 7520378
Site MX52004
Oaxaca, Mexico
Site BE32006
Leuven, Belgium, 3000
Site TW88603
Taichung, Taiwan, Province of China, 404
Site ES34010
Avila, Spain, 05004
Site DE49018
Dresden, Germany, 1067
Site JP81011
Osaka, Japan
Site KR82002
Seongnam-si, Republic of Korea, 13620
Site GB44101
London, United Kingdom, SW3 6JJ
Site PL48005
Wieliszew, Poland, 05-135
University of Chicago
Chicago, United States, 60637
Site JP81001
Suita, Japan
Site AU61011
Tugun, Australia, 4224
Site BE32004
Brussels, Belgium, 1000
Norton Cancer Institute
Louisville, United States, 40217
Site CA15009
Saint-John, Canada, E2L 4L4
Site IT39011
Meldola, Italy, 47014
Memorial Sloan Kettering Cancer Center
Basking Ridge, United States, 07920
Site PE51001
Lima, Peru, L27
Site IT39015
Roma, Italy, 00128
Site BE32008
Mons, Belgium, 7000
Memorial Hospital West
Pembroke Pines, United States, 33028
Site PL48007
Ostroleka, Poland, 07-410
University of Miami
Miami, United States, 33136
Site IT39012
Parma, Italy, 43126
Rhode Island Hospital-Lifespan Cancer Institute
Providence, United States, 02903
Site IT39004
Bergamo, Italy, 24127
Dana Farber Cancer Institute
Boston, United States, 02215
Site AU61002
Douglas, Australia, 4814
Site FR33007
Nice Cedex 2, France, 06189
Beth Israel Deaconess Medical Center
Boston, United States, 02215
Site FR33006
Poitiers, France, 86021
Site ES34003
Murcia, Spain, 30120
Site CO57005
Cali, Colombia
Site FR33011
Montpellier Cedex 5, France, 34298
Memorial Sloan Kettering Cancer Center
West Harrison, United States, 10604
Site FR33104
Saint Priest en Jarez, France, 42270
City of Hope Nat'l Medical Center
Duarte, United States, 91010
Memorial Sloan Kettering Cancer Center
Middletown, United States, 07748-3052
Site ES34011
Alcorcon, Spain, 28925
Site TW88606
Taipei, Taiwan, Province of China, 10002
The Ohio State University Medical Center
Columbus, United States, 43210
Roswell Park Cancer Institute
Buffalo, United States, 14263
The Angeles Clinic and Research Institute
Los Angeles, United States, 90025
Site GB44004
London, United Kingdom, W1G 6AD
Site ES34004
Madrid, Spain, 28034
Site FR33005
Nice, France, 06200
Memorial Sloan Kettering Cancer Center
Uniondale, United States, 11553
Memorial Sloan Kettering Cancer Center
New York, United States, 10065
Site IT39008
Milano, Italy, 20141
MultiCare Regional Cancer Center - Gig Harbor
Auburn, United States, 98801
St. Jude Hospital Yorba Linda
Fullerton, United States, 92835
Site KR82004
Seoul, Republic of Korea, 06351
The Valley Hospital
Paramus, United States, 07652
Site IT39023
Vicenza, Italy, 36100
Site CN86002
Beijing, China, 100071
Site DE49002
Mainz, Germany, 55101
Site BR55016
Passo Fundo, Brazil, 99010-260
Site KR82005
Seoul, Republic of Korea, 05505
Pacific Shores Medical Group
Huntington Beach, United States, 92648
Site ES34005
Barcelona, Spain, 08003
Site IL97209
Holon, Israel, 58100
Site IL97202
Jerusalem, Israel, 91031
Site BE32002
Bruxelles, Belgium, 1050
Site GB44003
Aberdeen, United Kingdom, AB25 2ZN
Site IL97206
Kfar Saba, Israel, 44281
Site CL56005
Santiago, Chile, 8330032
Site AU61008
Adelaide, Australia, 5011
Site ES34015
Barcelona, Spain, 08035
Site GB44002
London, United Kingdom, NW1 2PG
Site BR55018
Santa Catarina, Brazil, 88501-003
Site CN86005
Hefei, China, 230022
Maryland Oncology Hematology
Brandywine, United States, 20613
Site PE51006
Lima, Peru, 15072
Site CO57009
Bogota, Colombia, 110231
Site MX52008
San Luis de Potosi, Mexico, 78250
Site MX52009
Jalisco, Mexico, 45030
Site CA15011
Toronto, Canada, M5G 1X5
Site PL48009
Warszawa, Poland, 02-781
Site CN86009
Beijing, China, 100030
Site MX52007
Ciudad de México, Mexico, 3100
Site MX52010
Veracruz, Ver, Mexico, 91900
Site TW88609
Tainan, Taiwan, Province of China, 73657
Site TW88608
Kaohsiung, Taiwan, Province of China, 80756
Site DE49021
Halle, Germany, 06108
The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website
© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
POWERED BY:
